Vericel Corp. (VCEL)
40.19
-0.28
(-0.69%)
USD |
NASDAQ |
Sep 04, 16:00
40.19
0.00 (0.00%)
After-Hours: 20:00
Vericel Cash and Short Term Investments (Annual) : 137.50M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 137.50M |
| December 31, 2024 | 126.74M |
| December 31, 2023 | 127.34M |
| December 31, 2022 | 119.54M |
| December 31, 2021 | 103.40M |
| December 31, 2020 | 75.81M |
| December 31, 2019 | 69.72M |
| December 31, 2018 | 82.92M |
| December 31, 2017 | 26.86M |
| December 31, 2016 | 22.98M |
| December 31, 2015 | 14.58M |
| December 31, 2014 | 30.34M |
| December 31, 2013 | 8.059M |
| December 31, 2012 | 13.64M |
| December 31, 2011 | 5.53M |
| Date | Value |
|---|---|
| December 31, 2010 | 31.25M |
| June 30, 2009 | 17.28M |
| June 30, 2008 | 23.00M |
| June 30, 2007 | 29.10M |
| June 30, 2006 | 43.09M |
| June 30, 2005 | 32.41M |
| June 30, 2004 | 16.93M |
| June 30, 2003 | 10.51M |
| June 30, 2002 | 9.605M |
| June 30, 2001 | 10.66M |
| June 30, 2000 | 12.74M |
| June 30, 1999 | 7.528M |
| June 30, 1998 | 11.21M |
| June 30, 1997 | 17.01M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| AbbVie, Inc. | 5.257B |
| ADMA Biologics, Inc. | 87.63M |
| Kyntra Bio, Inc. | 88.98M |
| Conexeu Sciences, Inc. | 4.834M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |